Merck lays out expectations for 2008 (Philadelphia Business Journal)
Merck & Co. Inc. said Tuesday it expects to file two new drug applications next year and receive rulings next year on two other applications now under review by the Food and Drug Administration. (MRK)

AVAX Technologies Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 ... (wallstreet:online AG)
AVAX Technologies, Inc. (OTC Market:AVXT.OB) announced today the completion of its Phase I/II study